Merck & Co Inc (NYSE:MRK)

Friday’s Trading Day
58.44 -0.14 / -0.24%
Data as of Jul 11
Day’s Change
Monday’s Pre-Market   Switch to standard view »
58.42 -0.02 / -0.03%
 
Volume: 200.00
Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth?
7:01am / MotleyFool.com
Why These Dow "Dogs" Are Soaring in 2014
Jul 08 / MotleyFool.com
Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug - Analyst Blog
Jul 11 / Zacks.com
Markets Marginally Lower Ahead Of Earnings Season
Jul 07 / Benzinga
1 Drug More Important to Gilead Than Sovaldi
Jul 11 / MotleyFool.com
3 Stocks Reiterated As A Buy: EMC, MRK, MET
Jul 07 / TheStreet.com
Is This MannKind's Greatest Risk?
Jul 11 / MotleyFool.com
Make Your Move
Jul 07 / TheStreet.com
A Global Pharma Boom Is Coming... Here's How To Profit
Jul 11 / StreetAuthority
3 Things to Look for in MannKind's Partnership
Jul 04 / MotleyFool.com
Three Stocks That Pass Two Tough Tests
Jul 11 / TheStreet.com
Dow 30 Stock Roundup: Nike Beats on Q4 Earnings, AT&T to offload AMX Stake to Carlos ...
Jul 03 / Zacks.com
Jounce Taps Merck Vet to Lead Cancer Drug Push
Jul 10 / MotleyFool.com
Agenus Up on Positive Prophage Data - Analyst Blog
Jul 02 / Zacks.com
This Top Value Investment Tames Risk -- And Yields 3.8%
Jul 10 / StreetAuthority
Why Are These 3 Dow Jones Stocks Crushing the Market in 2014?
Jul 02 / MotleyFool.com
5 Big Trades to Conquer a Correcting Market
Jul 10 / TheStreet.com
3 Best Performing Stocks of June - Analyst Blog
Jul 02 / Zacks.com
Is This High-Yielding ETF Right For Your Portfolio?
Jul 09 / MotleyFool.com
Will Merck's Anti-PD-1 Therapy be the First to Launch? - Analyst Blog
Jul 01 / Zacks.com
3 Drugs Stocks Driving The Industry Higher
Jul 09 / TheStreet.com
Why Merck Should Buy Inovio, Seattle Genetics, or MannKind
Jul 01 / MotleyFool.com
Benefits Of Dividend & Blue Chip Investing
Jul 09 / Investing Channel
Why Investors are Wrong about Gilead
Jun 30 / MotleyFool.com
Low volatility is bad for 'low-vol' funds
Jul 09 / FT.com
Boeing Drags as the Dow Endures a Bouncy Day
Jun 30 / MotleyFool.com
Grading Sobek's Mid-Year Biotech Stock Predictions
Jul 09 / TheStreet.com
Mondaybs Top Biotech Stories: MannKind, Dicerna, Flamel, and Merck
Jun 30 / MotleyFool.com
Venezuela is wreaking havoc on big companies
Jul 09 / CNNMoney.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.